HB Wealth Management LLC Buys 13,621 Shares of Aflac Incorporated (NYSE:AFL)

Key Points

• HB Wealth Management LLC increased its holdings in Aflac Incorporated by 20.7% in the first quarter, bringing their total stake to approximately $8.82 million.
• Analysts have raised their price targets for Aflac, with a consensus target price of $108.15 and ratings varying from sell to buy.
• Aflac's recent earnings report indicated lower-than-expected revenue of $3.40 billion, down 37.5% year-over-year, and an EPS of $1.66, missing estimates by $0.01.

HB Wealth Management LLC grew its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 20.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 79,333 shares of the financial services provider's stock after acquiring an additional 13,621 shares during the quarter. HB Wealth Management LLC's holdings in Aflac were worth $8,821,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Golden State Wealth Management LLC boosted its position in Aflac by 121.9% in the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after buying an additional 167 shares in the last quarter. Garde Capital Inc. bought a new position in shares of Aflac during the first quarter worth about $36,000. Capital A Wealth Management LLC bought a new position in shares of Aflac during the fourth quarter worth about $38,000. NBC Securities Inc. bought a new position in Aflac during the first quarter worth $44,000. Finally, JCIC Asset Management Inc. bought a new stake in Aflac in the first quarter worth approximately $44,000. 67.44% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the sale, the director directly owned 6,728 shares in the company, valued at approximately $711,149.60. The trade was a 29.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the transaction, the director owned 26,096 shares of the company's stock, valued at $2,786,791.84. The trade was a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock valued at $4,304,295 in the last 90 days. 0.80% of the stock is currently owned by insiders.

Aflac Stock Down 1.3%

NYSE:AFL traded down $1.36 on Wednesday, reaching $99.47. 569,567 shares of the stock traded hands, compared to its average volume of 2,109,231. The company has a market capitalization of $53.78 billion, a price-to-earnings ratio of 15.54, a PEG ratio of 3.12 and a beta of 0.81. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $94.87 and a 12 month high of $115.50. The company's fifty day simple moving average is $102.83 and its 200 day simple moving average is $105.16.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business's revenue was down 37.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.66 EPS. Equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Wells Fargo & Company lifted their target price on Aflac from $103.00 to $105.00 and gave the stock an "equal weight" rating in a report on Thursday, July 10th. Barclays set a $98.00 target price on Aflac and gave the stock an "underweight" rating in a report on Monday, July 7th. UBS Group raised their price objective on Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Raymond James Financial reduced their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a research note on Thursday, May 29th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Aflac from $96.00 to $100.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $108.15.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.